News
-
MSD in $2B autoimmune buy
- 01 Mar 2021
Adding phase 1 investigative therapy to its pipeline.
Read more -
CSL’s $1b vax deal
- 24 Feb 2021
AusTender reveals government’s16 year deal with Seqirus for vaccines.
Read more -
Aus should stock up on meds, inquiry told
- 23 Feb 2021
Being an island helped Australia manage Covid but it’s not helpful when it comes to medicines supply, says Pfizer.
Read more -
Vertex steps up to the plate
- 18 Feb 2021
With all bases loaded, can Vertex score a home run with Trikafta?
Read more -
Merck sets sights on PBAC
- 04 Feb 2021
Local application reveals PBS intentions for this lung cancer first.
Read more -
Pfizer recovers from PBS slump
- 03 Feb 2021
Former darling of the PBS is rediscovering its mojo.
Read more -
PBAC says no to pan-tumour
- 01 Feb 2021
Attempt to get a recommendation for the rare cancer drug gets knocked back based on price but Bayer isn’t quitting yet.
Read more -
Pfizer boss leads on more than vaxes
- 01 Feb 2021
In telling his parents’ holocaust stories, Albert Bourla reveals the human side of this great corporate leader.
Read more